These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30532530)

  • 1. Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD.
    Tőkés-Füzesi M; Ruzsics I; Rideg O; Kustán P; Kovács GL; Molnár T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3749-3757. PubMed ID: 30532530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased microparticle levels in middle-aged and elderly patients with insomnia may be involved in the pathogenesis of arteriosclerosis.
    Xu B; Ma L; Zhang N; Guo W; Luo LM; Wang C; Jiang Y; Liu LG
    Int Angiol; 2020 Jun; 39(3):252-260. PubMed ID: 32052947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microparticles in chronic obstructive pulmonary disease.
    Takahashi T; Kubo H
    Int J Chron Obstruct Pulmon Dis; 2014; 9():303-14. PubMed ID: 24707174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.
    Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; He M; Yamada M; Suzuki S; Yanai M; Kurosawa S; Yamaya M; Kubo H
    Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study.
    Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; Tando Y; Yamada M; Yanai M; Yamaya M; Kurosawa S; Yamauchi M; Kubo H
    BMJ Open; 2014 Mar; 4(3):e004571. PubMed ID: 24604485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticles in sputum of COPD patients: a potential biomarker of the disease?
    Lacedonia D; Carpagnano GE; Trotta T; Palladino GP; Panaro MA; Zoppo LD; Foschino Barbaro MP; Porro C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():527-33. PubMed ID: 27042041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction.
    Li B; Huang Q; Lin C; Lu R; Wang T; Chen X; Liu Z; Liu Y; Wu J; Wu Y; Liao S; Ding X
    Life Sci; 2021 Jan; 265():118749. PubMed ID: 33220290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.
    Takeshita J; Mohler ER; Krishnamoorthy P; Moore J; Rogers WT; Zhang L; Gelfand JM; Mehta NN
    J Am Heart Assoc; 2014 Feb; 3(1):e000507. PubMed ID: 24584739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study.
    Thomashow MA; Shimbo D; Parikh MA; Hoffman EA; Vogel-Claussen J; Hueper K; Fu J; Liu CY; Bluemke DA; Ventetuolo CE; Doyle MF; Barr RG
    Am J Respir Crit Care Med; 2013 Jul; 188(1):60-8. PubMed ID: 23600492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
    Front Immunol; 2018; 9():322. PubMed ID: 29545790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD235a (Glycophorin-A) Is the Most Predictive Value Among Different Circulating Cellular Microparticles in Thrombocytopenic Human Immunodeficiency Virus Type 1.
    El-Menshawy N; Eissa M; Farag R; Aboalyazed A
    J Clin Lab Anal; 2016 May; 30(3):235-43. PubMed ID: 25716234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marathon running increases circulating endothelial- and thrombocyte-derived microparticles.
    Schwarz V; Düsing P; Liman T; Werner C; Herm J; Bachelier K; Krüll M; Brechtel L; Jungehulsing GJ; Haverkamp W; Böhm M; Endres M; Haeusler KG; Laufs U
    Eur J Prev Cardiol; 2018 Feb; 25(3):317-324. PubMed ID: 29183152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.
    Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; Tando Y; He M; Yamada M; Kurosawa S; Yamaya M; Kubo H
    Exp Lung Res; 2013; 39(4-5):155-61. PubMed ID: 23550836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Christersson C; Thulin Å; Siegbahn A
    Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Systemic Endothelial-Derived and Platelet-Derived Microparticles With Clinical Outcomes in Chronic Obstructive Pulmonary Disease.
    Lascano J; Katz J; Cearras M; Campos M
    Chronic Obstr Pulm Dis; 2021 Jul; 8(3):382-395. PubMed ID: 34062638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease.
    García-Lucio J; Peinado VI; de Jover L; Del Pozo R; Blanco I; Bonjoch C; Coll-Bonfill N; Paul T; Tura-Ceide O; Barberà JA
    PLoS One; 2018; 13(4):e0195724. PubMed ID: 29672621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.